Search database
Filter
1675
Featured
Language
Document type
1125
205
189
73
29
20
17
5
4
4
2
1
1
Countries
110
54
48
41
39
36
30
25
24
24
24
23
20
20
19
18
18
17
16
15
15
15
15
15
14
12
10
9
9
8
8
8
7
7
6
6
6
5
5
4
4
4
4
4
4
4
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
207
126
91
84
67
57
35
18
15
15
15
14
13
13
13
12
11
11
10
9
8
8
8
8
8
7
7
7
6
6
6
6
6
6
6
6
5
5
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Publication Years
Category
524
163
102
95
34
19
11
1
Toolboxes
547
98
64
59
48
42
38
33
27
27
23
20
20
17
16
13
12
6
5
4
4
2
1
The purpose of the Clinical Practice Guideline for Treatment of Patients with Anxiety Disorders in Primary Care is to provide professionals with practical recommendations based on scientific evidence to assist in the detection and effective treatmen ... more
This manual will contribute directly to the fourth focus area of the FAO Action Plan by promoting the prevention of infections and the prudent use of antibiotics in the pig and poultry sectors. The pig and poultry sectors are addressed together, as ... more

Global strategy to reduce the harmful use of alcohol

World Health Organization (2010) C_WHO
Specific measures are being taken within the National Tuberculosis Control Programme (NTP) to address the MDR TB problem through appropriate management of patients and strategies to prevent the propagation and dissemination of MDR TB.
The term "Programmatic Management of ... more

Field Guide for the Management of Drug-Resistant Tuberculosis

A. Piubello The International Union Against Tuberculosis and Lung Disease (2018)
A practical tool to help health workers in the clinical and operational management of multidrug-resistant tuberculosis with special focus on the introduction, implementation and management of the nine-month treatment regimen.
Infant Psychiatry Chapter B.1 Early Maltreatment and exposure to violence
mhGAP Training of Health-care Providers Training manual and Supporting material.
Dissertationsubmitted for the degree of Doctor of Philosophy, Brunel University
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
22 December 2021
The Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research (the framework) aims to provide values and principles, tools and mecha ... more
The "Stories from the field" document by the WHO Regional Office for the Eastern Mediterranean shares effective strategies from the Eastern Mediterranean Region for addressing noncommunicable diseases (NCDs) and mental health challenges, particularly during the COVID-19 pandemic. It highlights regio ... more
Alcohol consumption is deeply embedded in the social landscape of many societies. Several major factors have an impact on levels and patterns of alcohol consumption in populations – such as historical trends in alcohol consumption, the availability of alcohol, culture, economic status and trends i ... more
A review of available evidence (2016). 28-29 June 2016; Geneva, Switzerland The END TB strategy.
In support of the London Declaration goals, PATH aims to catalyze engagement of the diagnostics industry and product development efforts. As part of this work, PATH conducted a diagnostic landscape analysis to identify gaps and evaluated current and nascent HAT diagnostics that may provide solutions ... more
This analysis focused on the chronic form of HAT caused by T. b. gambiense, as it contributes to the majority of disease burden. Information from the literature review, product development landscape, and stakeholder interviews was compiled to: - Identify ... more

Executive Summary - Chapter 3 Pharmacological Treatment

R. Ali ATLAS on substance use (2010)— Resources for the prevention and treatment of substance use disorder; WHO (2019) C_WHO
ATLAS on substance use (2010)— Resources for the prevention and treatment of substance use disorder Accessed: 14.03.2019

Executive Summary - Chapter 4 Human Resources

M. E. Medina-Mora ATLAS on substance use (2010)— Resources for the prevention and treatment of substance use disorder; WHO (2019) C_WHO
ATLAS on substance use (2010)— Resources for the prevention and treatment of substance use disorder Accessed: 14.03.2019
WORLD DRUG REPORT 2017
Science Spotlight February 14, 2018

European Union - Overview

Drug War Facts; Common Sense for Drug Policy (2019) C2
Accessed: 28.03.2019
3rd edition

Treating Opioid Addiction in Criminal Justice Settings

National Institute on Drug Abuse (2017) C2

Executive Summary - Conclusions and policy implications

United Nations Office on Drugs and Crime; World Drug Report 2017 (2019) C2
World Drug Report 2017 -1- Accessed: 14.03.2019
The Best practice portal is a resource for professionals, policymakers and researchers in the drugs field. We provide information on the available evidence on drug-related prevention, treatment and harm reduction, focusing on the European context. T ... more

Synthetic cannabinoids in Europe

European Monitoring Centre for Drugs and Drug Addiction (2017) C2
Perspectives on Drugs
with recommended essential medicines for common diseases in patients in Stockholm County Council (Healthcare Region), Sweden
J Mov Disord > Volume 11(2); 2018 > Article Review Article J Mov Disord 2018; 11(2): 53-64. Published online: May 30, 2018 DOI: https://doi.org/10.14802/jmd.17028

Providing sutstainable mental and neurological health care in Ghana and Kenya

Sheena Posey Norris, Erin Hammers Forstag, and Bruce M. Altevogt Forum on Neuroscience and Nervous System Disorders; Board on Health Sciences Policy; Board on Global Health; Publisher: National Academic Press (2016) C2

Executive Summary - Chapter 6 Prevention

T. Stockwell ATLAS on substance use (2010)— Resources for the prevention and treatment of substance use disorder; WHO (2019) C_WHO
ATLAS on substance use (2010)— Resources for the prevention and treatment of substance use disorder Accessed: 14.03.2019

EMCDDA Monographs

T. Rhodes; D. Hedrich European Monitoring Centre for Drugs and Drug Addiction (2010) C2
Harm reduction: evidence, impacts and challenges -10-
Handbook of Foodborne Pathogenic Microorganisms and Natural Toxins
July 2021

Country overview: Georgia

J.D. Javakhishvili; L. Sturua; I. Kirtadze; et al. European Monitoring Centre for Drugs and Drug Addiction (2015) C2

Country overview: Kyrgyzstan

European Monitoring Centre for Drugs and Drug Addiction (2015) C2
Accessed: 22.03.2019

Country overview: Tajikistan

European Monitoring Centre for Drugs and Drug Addiction (2015) C2

Country overview: Kazakhstan

European Monitoring Centre for Drugs and Drug Addiction (2015) C2
Practical Guide on Trauma-Informed Approaches

Market Analysis of synthetic drugs

United Nations Office on Drugs and Crime; World Drug Report 2017 (2019) C2
Amphetamine-type stimulants, new psychoactive substances -4- World Drug Report 2017 Accessed: 14.03.2019

Developmental Disabilities

Institute of Medicine (US); Committee on Nervous System Disorders in Developing Countries; National Academy of Sciences (2001) C2
Neurological, Psychiatric, and Developmental Disorders: Meeting the Challenge in the Developing World Institute of Medicine (US) Committee on Nervous System Disorders in Developing Countries. Wash ... more
Mental health disorders remain widely under-reported — in our section on Data Quality & Definitions we discuss the challenges of dealing with this data. Figures presented in this entry should be taken as estimates of mental health disorder prevale ... more
International Journal of Drug Policy 24 (2013) e91-98
Manual for use in primary care. There is substantial evidence for the benefits of screening and brief intervention in primary health care for alcohol problems. However, there is a need for screening and brief interventions with cross-cultural rele ... more

Enuresis

A. von Gontard IACAPAP (2012) C2
Developmental disorders Chapter C.4

Encopresis

A. von Gontard IACAPAP (2012) C2
Developmental disorders Chapter C.5
World Drug Report 2018 -4-
Mood disorders Chapter E.2
Externalising disorders Chapter D.2
Mood disorders Chapter E.4 2018 edition
Anxiety disorders Chapter F.2
Other disorders Chapter H.5.1
Section I Somatoform disorders Child Psychiatry and Pediatrics Chapter I.1
Anxiety Disorders Chapter F.4
Developmental disorders Chapter C.3
Mood disorders Chapter E.1 2015 edition
Mood disorders Chapter E.3 2016 edition
Anxiety disorders Chapter F.3
Anxiety disorders Chapter F.5
Other disorders Chapter H.3
Externalizing disorders Chapter 1.1
This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and health professionals involved in HIV/AIDS prevention and treatment programmes. A number of WHO publica ... more
Alcohol use is deeply embedded in the social landscape of many societies, and some 2300 million people drink alcoholic beverages in most parts of the world. At the same time, more than half of the global population aged 15 years and older reported h ... more
املعالجة الرسيرية لالضطرابات النفسية والعصبية واستخدام مواد اإلدمان يف حاالت الطوارئ اإلنسانية Mhgap Humanitarian Intervention Guide (mhGAP-HIG): Clinical management of mental, neurological and substance ... more
Developmental disorders Chapter C.2 2014 Edition
Mental disorders are one of the top public health challenges in the WHO European Region, affecting about 25% of the population every year. In all countries, mental health problems are much more prevalent among the people who are most deprived. The W ... more

Service Delivery - Chapter 6

World Health Organization (WHO) World Health Organization (WHO) (2020) C_WHO
Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection Accessed: 26.02.2020
The harmful use of alcohol causes approximately 3 million deaths every year and the overall burden of disease and injuries attributable to alcohol consumption remains unacceptably high. The pace of development and implementation of alcohol policies ... more
Addressing comorbidity between mental disorders and major noncommunicable diseases (Russian Version)
Информационный бюллетень Июнь 2020 г. Уязвимые группы населения в контексте ответных мер в отношении COVID-19 Vulnerable populations during COVID-19 response - ... more
Regulation of the Minister of Health of the Republic of Indonesia on Impact Reduction for Injecting Narcotics Drug Users NAPZA : Narkotika, Psikotropika dan Zat Adiktif Lainnya (Narcotics, Psychotropic and Other Addictive Substances)

Out of the Shadows. Making Mental Health a Global Development Policy

Seth Mnookin World Bank Group, and World Health Organization WHO (2016) C_WHO
Mental disorders impose an enormous burden on society, accounting for almost one in three years lived with disability globally. •In addition to their health impact, mental disorders cause a signif ... more
For each medicine the Formulary provides information on use, dosage, adverse effects, contraindications and warnings, supplemented by guidance on selecting the right medicine for a range of conditions
This diagnostic and treatment manual is designed for use by medical professionals involved in curative care at the dispensary and hospital levels. We have tried to respond in the simplest and most practical way possible to the questions and problems ... more
The objective of this book is to provide health workers with easily accessible information on important aspects of the medicines commonly used at primary care level in Zimbabwe. Medicines are a crucial part of the management of most of our patients, yet many medicines are potentially dangerous if no ... more
1. Provide treatment for mental disorders in primary care 2. Ensure wider accessibility to essential psychotropic drugs 3. Provide care in the community 4. Educate the public 5. Involve communities, families and consumers 6. Establish national ... more
Supplement to the 2016 consolidated Guidelines on the use of antiretroviral drugs for Treating and Preventing HIV infection HIV Treatment
IACAPAP Textbook of Child and Adolescent Mental Health Child psychiatry & pediatrics Chapter I.1 Somatoform disorders
Developing protocols for use with refugees and internally displaced persons
Q10: In individuals with psychotic disorders (including schizophrenia) and bipolar disorders are psychoeducation, family interventions and cognitive-behavioural therapy feasible and effective?
Stigma toward individuals with mental disorders has been studied extensively. In the case of Latin America and the Caribbean, the past decade has been marked by a significant increase in information on stigma toward mental illness, but these findi ... more
Download (7.4 MB) Overview Epilepsy is one of the most common neurological disorders globally. The WHO epilepsy technical brief aims to strengthen action for epilepsy and complements the Intersectoral global action plan on epilepsy and other neuro ... more
Non-Communicable Diseases (NCDs), including mental disorders, currently pose one of the biggest threats to health and development globally, particularly in low and middle income countries2. It is predicted that unless proven interventions are rapidl ... more

Social determinants of mental health

Fundação Calouste Gulbenkian World Health Organization WHO (2014) C_WHO
Good mental health is integral to human health and well being. A person’s mental health and many common mental disorders are shaped by various social, economic, and physical environments operating at different stages of life. Risk factors for many ... more

Health, Rights and Drugs

UNAIDS (2019) C_WHO
Harm Reducation, Decriminalization and Zero Discrimination for People who use Drugs
Reporting system for the general public - This document aims to provide practical guidelines on how to set up national systems for consumers to report adverse reactions to medicines. The purpose is to help countries set up a well-organized and effective consumer reporting system within their pharmac ... more
Epilepsy is one of the world’s most common chronic neurological disorders. Roughly 50 million people suffer from it, 5 million of them in the Region of the Americas . Nevertheless, it is estimated that over 50% of these people in Latin America a ... more

The Manas Programm Doctor's Manual

Manashanti Sudhar Shodh Sangath; London School of Hygiene & Tropical Medicine (2011) CC
A Program To Improve The Care For Patients With Common Mental Disorders In Primary Health Care. The essence of the MANAS model is to shift mental health care from mental health specialists to primarycare doctors and lay HCs (s ... more
Symptom-based integrated approach to the adult in primary care. Primary Care 101 is a comprehensive clinical practice guideline that aims to equip nurses and other clinicians to diagnose and manage common adult conditions at primary level. Tb; HIV; Asthma/COPD; cardiovascular disease; diabetes; M ... more
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis, ... more
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world. In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f ... more
Overview Learning objectives • Promote respect and dignity for people with depression. • Recognize common symptoms of depression. • Know the assessment principles of depression. • Know the management principles of depression. • Perform an assessment for depression. • ... more
The aim of this paper is to investigate how doctors working in primary health care in Latin American address patients with common mental disorders and to investigate how stigma can affect their clinical decisions PLoSONE 13(11):e0206440.https://do ... more
This third regional report discusses gaps and challenges in reducing the harmful use of alcohol and how countries can reverse current trends in a cost-effective and expedited way.
УСПЕХИ В РЕАЛИЗАЦИИ ПОЛИТИКИ В ОТНОШЕНИИ КОНТРОЛЯ НАД АЛКОГОЛЬНОЙ ПРОДУКЦИЕЙ, 2010–2019 ГГ A detailed overview is provided of the implementation of alcohol policies described in the 10 action areas of the European Action Plan ... more